Bio-Techne Corporation

(NASDAQ:TECH)

Latest On Bio-Techne Corporation (TECH):

Date/Time Type Description Signal Details
2024-08-19 05:54 ESTDividendA dividend of $0.08 has been announced on Aug 7, 2024. It will be paid Aug 30, 2024 with an ex-dividend date of Aug 19, 2024.Neutral
2024-05-10 05:54 ESTDividendA dividend of $0.08 has been announced on May 1, 2024. It will be paid May 24, 2024 with an ex-dividend date of May 10, 2024.Neutral
2024-02-09 04:54 ESTDividendA dividend of $0.08 has been announced on Feb 1, 2024. It will be paid Feb 26, 2024 with an ex-dividend date of Feb 9, 2024.Neutral
2023-11-09 04:54 ESTDividendA dividend of $0.08 has been announced on Oct 31, 2023. It will be paid Nov 24, 2023 with an ex-dividend date of Nov 9, 2023.Neutral
2023-08-17 05:53 ESTDividendA dividend of $0.08 has been announced on Aug 8, 2023. It will be paid Sep 1, 2023 with an ex-dividend date of Aug 17, 2023.Neutral
2023-05-19 01:49 ESTNewsBio-Techne Corporation: Long-Term Quality, But At A PriceN/A
2023-05-12 05:54 ESTDividendA dividend of $0.08 has been announced on May 3, 2023. It will be paid May 26, 2023 with an ex-dividend date of May 12, 2023.Neutral
2023-05-03 16:01 ESTNewsBio-Techne Non-GAAP EPS of $0.53 in-line, revenue of $294.1M misses by $4.45MN/A
2023-05-03 16:00 ESTNewsBio-Techne Corporation (TECH) Q3 2023 Earnings Call TranscriptN/A
2023-05-02 14:56 ESTNewsBio-Techne Q3 2023 Earnings PreviewN/A
2023-02-10 04:53 ESTDividendA dividend of $0.08 has been announced on Feb 2, 2023. It will be paid Feb 27, 2023 with an ex-dividend date of Feb 10, 2023.Neutral
2023-02-03 00:10 ESTNewsBio-Techne Corporation (TECH) Q2 2023 Earnings Call TranscriptN/A
2023-02-02 10:00 ESTNewsBio-Techne Non-GAAP EPS of $0.47 misses by $0.02, revenue of $271.58M misses by $18.15MN/A
2023-02-02 10:00 ESTNewsBio-Techne declares $0.08 dividendN/A
2023-01-27 13:47 ESTNewsBio-Techne: Paring Rating Back To Neutral Until Growth Drivers Stack UpN/A
2023-01-10 14:38 ESTNewsAgilent, Bio-Techne upgraded as Wells Fargo revises life sciences outlookN/A
2022-11-15 08:34 ESTNewsBio-Techne opens new immunoassay manufacturing facilityN/A
2022-11-11 17:52 ESTNewsBio-Techne: Recent Weakness, Charts Suggest It's Now A Buy (Technical Analysis)N/A
2022-11-10 04:54 ESTDividendA dividend of $0.32 has been announced on Nov 1, 2022. It will be paid Nov 28, 2022 with an ex-dividend date of Nov 10, 2022.Neutral
2022-11-01 16:14 ESTNewsBio-Techne declares $0.32 dividend; announces 4-for-1 split in form of stock dividendN/A
2022-11-01 16:14 ESTNewsBio-Techne Non-GAAP EPS of $1.78 misses by $0.05, revenue of $269.65M misses by $12.08MN/A
2022-11-01 16:13 ESTNewsBio-Techne (TECH) Q1 2023 Earnings Call TranscriptN/A
2022-10-11 21:07 ESTNewsBio-Techne releases new AVV viral titer assaysN/A
2022-09-01 12:12 ESTNewsBio-Techne to seek shareholder approval for 4- for-1 stock splitN/A
2022-08-19 02:11 ESTNewsBio-Techne releases Quantist Luminex data analysis softwareN/A
2022-08-12 05:54 ESTDividendA dividend of $0.32 has been announced on Aug 4, 2022. It will be paid Aug 29, 2022 with an ex-dividend date of Aug 12, 2022.Neutral
2022-08-07 11:55 ESTNewsBio-Techne Corporation (TECH) CEO Chuck Kummeth on Q4 2022 Results - Earnings Call TranscriptN/A
2022-08-04 17:36 ESTNewsBio-Techne Non-GAAP EPS of $2.05 misses by $0.03, revenue of $288.2M beats by $1.16MN/A
2022-08-04 17:36 ESTNewsBio-Teche announces transition plan for CEO KummethN/A
2022-08-04 02:31 ESTNewsBio-Techne Q4 2022 Earnings PreviewN/A
2022-07-29 19:06 ESTNewsBio-Techne: Resiliency Comes At A Large PremiumN/A
2022-07-06 11:30 ESTNewsBio-Techne launches HPV detection test RNAscope in Europe for use in throat cancerN/A
2022-06-22 08:32 ESTNewsBio-Techne to acquire single-cell sorting platform provider NamocellN/A
2022-05-13 05:54 ESTDividendA dividend of $0.32 has been announced on Nov 30, -0001. It will be paid May 27, 2022 with an ex-dividend date of May 13, 2022.Neutral
2022-05-04 13:07 ESTNewsBio-Techne Non-GAAP EPS of $2.14 beats by $0.14, revenue of $290.4M beats by $11.13MN/A
2022-05-04 13:06 ESTNewsBio-Techne Corporation (TECH) CEO Chuck Kummeth On Q3 2022 Results - Earnings Call TranscriptN/A
2022-05-03 21:16 ESTNewsBio-Techne Q3 2022 Earnings PreviewN/A
2022-03-23 14:45 ESTNewsBio-Techne - Exceptional Leverage To Biopharma Growth, And Priced AccordinglyN/A
2022-02-22 11:21 ESTNewsBio-Techne, Thermo Fisher ink contract to develop/sell kidney transplant rejection testN/A
2022-02-10 04:54 ESTDividendA dividend of $0.32 has been announced on Feb 1, 2022. It will be paid Feb 25, 2022 with an ex-dividend date of Feb 10, 2022.Neutral
2022-02-01 16:46 ESTNewsBio-Techne Non-GAAP EPS of $1.88 beats by $0.09, revenue of $269.28M beats by $2.71MN/A
2022-02-01 16:46 ESTNewsBio-Techne declares $0.32 dividend and repurchase of $400M of common stockN/A
2022-02-01 16:45 ESTNewsBio-Techne Corporation (TECH) CEO Chuck Kummeth on Q2 2022 Results - Earnings Call TranscriptN/A
2022-01-31 23:29 ESTNewsBio-Techne FQ2 2022 Earnings PreviewN/A
2022-01-05 11:13 ESTNewsAkoya Biosciences, Bio-Techne team up to develop spatial multiomics workflowN/A
2021-12-14 22:44 ESTNewsBio-Techne enters option agreement with Wilson WolfN/A
2021-12-03 21:34 ESTNewsBio-Techne Is Overpriced - Here's WhyN/A
2021-11-10 04:55 ESTDividendA dividend of $0.32 has been announced on Nov 2, 2021. It will be paid Nov 26, 2021 with an ex-dividend date of Nov 10, 2021.Neutral
2021-11-03 00:17 ESTNewsBio-Techne EPS beats by $0.11, beats on revenueN/A
2021-11-03 00:16 ESTNewsBio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2022 Results - Earnings Call TranscriptN/A

About Bio-Techne Corporation (TECH):

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates in two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers proteins and reagent solutions, including cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and T-Cell activation technologies. This segment also provides manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays comprising the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

See Advanced Chart

General

  • Name Bio-Techne Corporation
  • Symbol TECH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 2,300
  • Last Split Factor2:1
  • Last Split Date2000-12-04
  • Fiscal Year EndJune
  • IPO Date1989-02-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryLife Sciences Tools & Services
  • Gic SubIndustryLife Sciences Tools & Services
  • Web URLhttp://www.bio-techne.com
View More

Valuation

  • Trailing PE 84.84
  • Forward PE 55.87
  • Price/Sales (Trailing 12 Mt.) 19.01
  • Price/Book (Most Recent Quarter) 9.73
  • Enterprise Value Revenue 18.57
  • Enterprise Value EBITDA 48.61
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $6.10
  • Next Year EPS Estimate $7.12
  • Next Quarter EPS Estimate $1.47
  • Profit Margin 22%
  • Operating Margin 23%
  • Return on Assets 6%
  • Return on Equity 12%
  • Revenue 798.97 million
  • Earnings Per Share $4.40
  • Revenue Per Share $20.78
  • Gross Profit 483.19 million
  • Quarterly Earnings Growth 21.3%
View More

Highlights

  • Market Capitalization 14.47 billion
  • EBITDA 234.26 million
  • PE Ratio 69.82
  • PEG Ratio 3.09
  • Analyst Target Price $417.22
  • Book Value Per Share $39.26
View More

Share Statistics

  • Shares Outstanding 38.8 million
  • Shares Float 38.57 million
  • % Held by Insiders 59%
  • % Held by Institutions 95.81%
  • Shares Short 278617
  • Shares Short Prior Month 339766
  • Short Ratio 1.31
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.11
  • 52 Week High $414.99
  • 52 Week Low $154.5
  • 50 Day Moving Average 373.31
  • 200 Day Moving Average 309.85
View More

Dividends

  • Forward Annual Dividend Rate $1.28
  • Forward Annual Dividend Yield 0.34%
  • Payout Ratio 24%
  • Dividend Date 2021-02-26
  • ExDividend Date 2021-02-11
  • Dividend Per Share $1.28
  • Dividend Yield 0.43%
View More

Bio-Techne Corporation (TECH) Dividend Calendar:

Bio-Techne Corporation pays an annual dividend of $1.28 per share, with a dividend yield of 0.43%.
TECH's last dividend payment was made to shareholders on February 26, 2021.
Bio-Techne Corporation pays out 24% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Bio-Techne Corporation (TECH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-02$224.25 million$1.62$1.3718.16%
2020-09-302020-11-05$204.2 million$1.43$1.1029.61%
2020-06-302020-08-04$175.83 million$1.00$0.7630.99%
2020-03-312020-04-30$N/A$1.39$1.1322.67%
2019-12-312020-02-04$184.93 million$1.08$1.14-4.98%
2019-09-302019-10-29$183.24 million$1.06$1.060.19%
2019-06-302019-08-06$191.66 million$1.25$1.34-6.54%
2019-03-312019-04-30$184.86 million$1.21$1.173.33%
2018-12-312019-02-05$174.51 million$1.06$1.014.75%
2018-09-302018-10-30$162.97 million$0.98$0.970.55%
2018-06-302018-08-07$180.25 million$1.34$1.293.86%
2018-03-312018-05-02$163.97 million$1.21$1.146.12%
2017-12-312018-02-06$154.15 million$1.02$0.9211.03%
2017-09-302017-10-31$144.61 million$0.90$0.882.12%
2017-06-302017-08-08$156.58 million$1.09$0.9910.01%
2017-03-312017-05-02$144.04 million$0.97$0.934.86%
2016-12-312017-02-07$131.81 million$0.81$0.84-3.71%
2016-09-302016-10-31$130.58 million$0.84$0.796.06%
2016-06-302016-08-17$134.76 million$0.92$0.94-2.34%
2016-03-312016-05-03$130.97 million$1.01$0.8913.06%
2015-12-312016-02-02$120.91 million$0.88$0.827.1%
2015-09-302015-10-28$112.38 million$0.79$0.85-7.06%
2015-06-302015-08-06$117.66 million$0.87$0.861.16%
2015-03-312015-05-05$114.16 million$0.86$0.90-4.44%
2014-12-312015-02-03$111.95 million$0.82$0.86-4.65%
2014-09-302014-10-28$108.48 million$0.85$0.87-2.3%
2014-06-302014-08-11$92.52 million$0.88$0.853.53%
2014-03-312014-04-28$95.56 million$0.94$0.895.62%
2013-12-312014-02-04$84.02 million$0.75$0.80-6.25%
2013-09-302013-10-29$85.67 million$0.83$0.803.75%
2013-06-302013-08-06$79.48 million$0.82$0.83-1.2%
2013-03-312013-04-30$80.99 million$0.88$0.90-2.22%
2012-12-312013-02-05$75.08 million$0.74$0.77-3.9%
2012-09-302012-10-23$75.03 million$0.75$0.80-6.25%
2012-06-302012-07-31$78.68 million$0.80$0.85-5.88%
2012-03-312012-05-01$83.62 million$0.90$0.891.12%
2011-12-312012-01-31$74.66 million$0.76$0.79-3.8%
2011-09-302011-10-25$77.6 million$0.81$0.84-3.57%
2011-06-302011-08-02$78.04 million$0.85$0.7710.39%
2011-03-312011-05-03$76.27 million$0.84$0.805%
2010-12-312011-02-01$67.71 million$0.69$0.681.47%
2010-09-302010-10-26$67.95 million$0.71$0.73-2.74%
2010-06-302010-08-03$66.71 million$0.69$0.71-2.82%
2010-03-312010-05-04$70.28 million$0.75$0.79-5.06%
2009-12-312010-02-02$65.52 million$0.66$0.68-2.94%
2009-09-302009-10-28$66.53 million$0.72$0.702.86%
2009-06-302009-08-04$64.89 million$0.68$0.69-1.45%
2009-03-312009-04-28$67.87 million$0.74$0.722.78%
2008-12-312009-02-03$61.88 million$0.62$0.64-3.13%
2008-09-302008-10-22$69.32 million$0.74$0.6612.12%
2008-06-302008-08-05$67.77 million$0.70$0.674.48%
2008-03-312008-04-29$69.52 million$0.76$0.6615.15%
2007-12-312008-01-29$62.14 million$0.60$0.5411.11%
2007-09-302007-10-24$57.99 million$0.58$0.571.75%
2007-06-302007-08-07$58.43 million$0.58$0.571.75%
2007-03-312007-05-01$60.2 million$0.60$0.600%
2006-12-312007-01-30$52.51 million$0.47$0.48-2.08%
2006-09-302006-10-25$52.35 million$0.50$0.492.04%
2006-06-302006-08-08$52.07 million$0.49$0.50-2%
2006-03-312006-04-25$54.81 million$0.52$0.504%
2005-12-312006-01-31$48.03 million$0.42$0.412.44%
2005-09-302005-10-27$47.71 million$0.43$0.422.38%
2005-06-302005-08-16$47.55 million$0.47$0.439.3%
2005-03-312005-04-26$47.94 million$0.45$0.427.14%
2004-12-312005-02-01$42.25 million$0.36$0.352.86%
2004-09-302004-10-21$40.92 million$0.34$0.35-2.86%
2004-06-302004-08-10$42.46 million$0.32$0.35-8.57%
2004-03-312004-04-27$42.54 million$0.35$0.336.06%
2003-12-312004-01-27$38.26 million$0.30$0.293.45%
2003-09-302003-10-23$37.99 million$0.30$0.287.14%
2003-06-302003-08-12$39.43 million$0.31$0.303.33%
2003-03-312003-05-01$37.74 million$0.30$0.2711.11%
2002-12-312003-01-28$33.3 million$0.23$0.25-8%
2002-09-302002-10-25$34.55 million$0.25$0.250%
2002-06-302002-08-13$35.64 million$0.26$0.254%
2002-03-312002-04-23$34.29 million$0.25$0.244.17%
2001-12-312002-01-29$31.14 million$0.20$0.21-4.76%
2001-09-302001-10-18$29.84 million$0.20$0.195.26%
2001-06-302001-08-14$30.71 million$0.22$0.220%
2001-03-312001-05-01$30.24 million$0.21$0.205%
2000-12-312001-01-30$26.69 million$0.16$0.160%
2000-09-302000-10-24$27.72 million$0.18$0.180%
2000-06-302000-08-15$27.31 million$0.20$0.1717.65%
2000-03-312000-04-25$26.78 million$0.18$0.1428.57%
1999-12-312000-02-08$0.13$0.1118.18%
1999-09-301999-10-21$0.12$0.119.09%
1999-06-301999-08-10$0.12$0.120%
1999-03-311999-04-26$0.11$0.110%
1998-12-311999-02-02$0.09$0.0812.5%
1998-09-301998-10-22$0.09$0.0728.57%
1998-06-301998-08-11$0.13$0.1118.18%
1998-03-311998-04-28$0.10$0.0911.11%
1997-12-311998-02-03$0.08$0.080%
1997-09-301997-10-23$0.08$0.080%
1997-06-301997-08-12$0.09$0.0812.5%
1997-03-311997-04-22$0.08$0.0714.29%
1996-12-311997-01-28$0.06$0.060%
1996-09-301996-10-24$0.06$0.060%
1996-06-301996-08-15$0.07$0.070%
1996-03-311996-04-22$0.07$0.0616.67%
1995-12-311995-12-31$0.04
1995-09-301995-09-30$0.05
1995-06-301995-06-30$0.05
1995-03-311995-03-31$0.05

Bio-Techne Corporation (TECH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Bio-Techne Corporation (TECH) Chart:

Bio-Techne Corporation (TECH) News:

Below you will find a list of latest news for Bio-Techne Corporation (TECH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Bio-Techne Corporation (TECH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-11-15400CALL0 098.06TRUE00
2024-11-15450CALL0 068.37TRUE00
2024-11-15500CALL0 050.31TRUE00
2024-11-15550CALL0 056.7TRUE00
2024-11-15600CALL0 049.55TRUE00
2024-11-15650CALL0 047.07TRUE00
2024-11-15700CALL0 045.37TRUE00
2024-11-15756.15CALL10 038.5TRUE6.150
2024-11-15802.3CALL0 835.39FALSE00
2024-11-15851.55CALL12 90434.63FALSE-0.65-0.3
2024-11-15900CALL0 043.34FALSE00
2024-11-15950CALL0 00FALSE00
2024-11-151000CALL0 00FALSE00
2024-11-151050CALL0 00FALSE00
2024-11-151100.15CALL0 20FALSE00
2024-11-151150.25CALL0 40FALSE00
2024-11-15400PUT0 00FALSE00
2024-11-15450PUT0 00FALSE00
2024-11-15500PUT0 00FALSE00
2024-11-15550PUT0 00FALSE00
2024-11-15600PUT0 00FALSE00
2024-11-15650PUT0 00FALSE00
2024-11-15700PUT0 044.32FALSE00
2024-11-15753.12PUT0 1935.13FALSE00
2024-11-15800PUT0 030.49TRUE00
2024-11-15850PUT0 035.19TRUE00
2024-11-15900PUT0 035.01TRUE00
2024-11-15950PUT0 041.92TRUE00
2024-11-151000PUT0 045.49TRUE00
2024-11-151050PUT0 047.16TRUE00
2024-11-151100PUT0 056.57TRUE00
2024-11-151150PUT0 058.92TRUE00
2025-01-17400CALL0 068.75TRUE00
2025-01-17450CALL0 055.29TRUE00
2025-01-17500CALL0 054.74TRUE00
2025-01-17550CALL0 046.87TRUE00
2025-01-17600CALL0 041.35TRUE00
2025-01-176518.9CALL0 139.07TRUE00
2025-01-177013.24CALL0 037.54TRUE00
2025-01-17757.74CALL0 6635.33TRUE00
2025-01-17807.5CALL0 2336.48FALSE00
2025-01-17854CALL0 3633.56FALSE00
2025-01-17901.78CALL0 533.16FALSE00
2025-01-17951.6CALL0 537.57FALSE00
2025-01-171000CALL0 041.16FALSE00
2025-01-171050CALL0 00FALSE00
2025-01-171100CALL0 00FALSE00
2025-01-171150CALL0 00FALSE00
2025-01-171200.7CALL0 140FALSE00
2025-01-171250.6CALL0 250FALSE00
2025-01-17400PUT0 00FALSE00
2025-01-17450.85PUT0 10FALSE00
2025-01-17501.25PUT0 10FALSE00
2025-01-17551.65PUT0 1561.18FALSE00
2025-01-17602.4PUT0 1153.17FALSE00
2025-01-17651.65PUT0 1742.49FALSE00
2025-01-17702.6PUT0 1338.16FALSE00
2025-01-17750PUT0 036.27FALSE00
2025-01-17800PUT0 035.15TRUE00
2025-01-17850PUT0 032.72TRUE00
2025-01-17900PUT0 031.76TRUE00
2025-01-17950PUT0 032.34TRUE00
2025-01-171000PUT0 035.29TRUE00
2025-01-1710526.9PUT0 040.36TRUE00
2025-01-171100PUT0 039.71TRUE00
2025-01-171150PUT0 047.3TRUE00
2025-01-171200PUT0 047.75TRUE00
2025-01-171250PUT0 051.47TRUE00
2025-04-17400CALL0 049.44TRUE00
2025-04-17450CALL0 044.4TRUE00
2025-04-17500CALL0 043.67TRUE00
2025-04-17550CALL0 042.75TRUE00
2025-04-17600CALL0 038.85TRUE00
2025-04-17650CALL0 037.7TRUE00
2025-04-17700CALL0 035.41TRUE00
2025-04-17750CALL0 035.91TRUE00
2025-04-17800CALL0 034.4FALSE00
2025-04-17856.1CALL0 733.53FALSE00
2025-04-17903CALL0 1032.69FALSE00
2025-04-17952.13CALL0 232.1FALSE00
2025-04-171002.61CALL0 831.15FALSE00
2025-04-171050CALL0 033.82FALSE00
2025-04-171100CALL0 00FALSE00
2025-04-17400PUT0 00FALSE00
2025-04-17450PUT0 00FALSE00
2025-04-17500PUT0 00FALSE00
2025-04-17552PUT0 10FALSE00
2025-04-17602.76PUT0 10FALSE00
2025-04-17652.75PUT0 137.84FALSE00
2025-04-17704.1PUT0 535.34FALSE00
2025-04-17750PUT0 035.12FALSE00
2025-04-17800PUT0 033.88TRUE00
2025-04-17850PUT0 031.5TRUE00
2025-04-17900PUT0 030.04TRUE00
2025-04-17950PUT0 029.9TRUE00
2025-04-171000PUT0 029.87TRUE00
2025-04-171050PUT0 032.18TRUE00
2025-04-171100PUT0 034.15TRUE00

Latest TECH Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST18$325.34
Jun 13, 2022 7:59 PM EST45$325.34
Jun 13, 2022 7:59 PM EST4$325.06
Jun 13, 2022 7:59 PM EST2$325.06
Jun 13, 2022 7:59 PM EST4$325.34

Bio-Techne Corporation (TECH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000021545718005898/0000215457-18-005898-index.htm
2019-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000021545719000933/0000215457-19-000933-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000083423720001545/0000834237-20-001545-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000083423720009053/0000834237-20-009053-index.htm
2018-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000256/0000914190-19-000256-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000257/0000914190-19-000257-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000258/0000914190-19-000258-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000259/0000914190-19-000259-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000260/0000914190-19-000260-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000261/0000914190-19-000261-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000308/0000914190-19-000308-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000328/0000914190-19-000328-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000329/0000914190-19-000329-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000330/0000914190-19-000330-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000331/0000914190-19-000331-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000370/0000914190-19-000370-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000476/0000914190-19-000476-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000519/0000914190-19-000519-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000520/0000914190-19-000520-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000018/0000914190-20-000018-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000070/0000914190-20-000070-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000109/0000914190-20-000109-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000160/0000914190-20-000160-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000167/0000914190-20-000167-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000186/0000914190-20-000186-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000245/0000914190-20-000245-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000247/0000914190-20-000247-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000249/0000914190-20-000249-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000251/0000914190-20-000251-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000253/0000914190-20-000253-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000289/0000914190-20-000289-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000290/0000914190-20-000290-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000291/0000914190-20-000291-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000091419020000292/0000914190-20-000292-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000093247119004923/0000932471-19-004923-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000110465920017773/0001104659-20-017773-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000139834419002785/0001398344-19-002785-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774918009213/0001437749-18-009213-index.htm
2018-05-25SDhttps://www.sec.gov/Archives/edgar/data/842023/000143774918010740/0001437749-18-010740-index.htm
2018-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918012358/0001437749-18-012358-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918014310/0001437749-18-014310-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918014634/0001437749-18-014634-index.htm
2018-08-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774918016190/0001437749-18-016190-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918016625/0001437749-18-016625-index.htm
2018-09-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/842023/000143774918016854/0001437749-18-016854-index.htm
2018-09-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/842023/000143774918016855/0001437749-18-016855-index.htm
2018-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918018887/0001437749-18-018887-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774918018994/0001437749-18-018994-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774918019736/0001437749-18-019736-index.htm
2018-11-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/842023/000143774918019746/0001437749-18-019746-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919001827/0001437749-19-001827-index.htm
2019-02-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774919002066/0001437749-19-002066-index.htm
2019-04-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/842023/000143774919007189/0001437749-19-007189-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919008208/0001437749-19-008208-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774919008875/0001437749-19-008875-index.htm
2019-05-29SDhttps://www.sec.gov/Archives/edgar/data/842023/000143774919010933/0001437749-19-010933-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919012693/0001437749-19-012693-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919015521/0001437749-19-015521-index.htm
2019-08-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774919017565/0001437749-19-017565-index.htm
2019-09-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/842023/000143774919018072/0001437749-19-018072-index.htm
2019-09-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/842023/000143774919018073/0001437749-19-018073-index.htm
2019-10-0910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774919019836/0001437749-19-019836-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774919020780/0001437749-19-020780-index.htm
2019-11-0610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774919021760/0001437749-19-021760-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774919021764/0001437749-19-021764-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774920001618/0001437749-20-001618-index.htm
2020-02-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774920001901/0001437749-20-001901-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774920008902/0001437749-20-008902-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/842023/000143774920010135/0001437749-20-010135-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774920011291/0001437749-20-011291-index.htm
2020-05-29SDhttps://www.sec.gov/Archives/edgar/data/842023/000143774920011970/0001437749-20-011970-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774920016374/0001437749-20-016374-index.htm
2020-08-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/842023/000143774920018754/0001437749-20-018754-index.htm
2020-09-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/842023/000143774920019750/0001437749-20-019750-index.htm
2020-09-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/842023/000143774920019751/0001437749-20-019751-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774920022390/0001437749-20-022390-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/842023/000143774920022618/0001437749-20-022618-index.htm
2018-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018002166/0001562180-18-002166-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018002455/0001562180-18-002455-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018002938/0001562180-18-002938-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003542/0001562180-18-003542-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003543/0001562180-18-003543-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003544/0001562180-18-003544-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003561/0001562180-18-003561-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018003802/0001562180-18-003802-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004303/0001562180-18-004303-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004304/0001562180-18-004304-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004305/0001562180-18-004305-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004306/0001562180-18-004306-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004307/0001562180-18-004307-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004308/0001562180-18-004308-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218018004309/0001562180-18-004309-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019002478/0001562180-19-002478-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003526/0001562180-19-003526-index.htm
2019-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003803/0001562180-19-003803-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003807/0001562180-19-003807-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020003482/0001562180-20-003482-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2020-08-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020005326/0001562180-20-005326-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020005331/0001562180-20-005331-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006487/0001562180-20-006487-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006488/0001562180-20-006488-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006489/0001562180-20-006489-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006491/0001562180-20-006491-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006492/0001562180-20-006492-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006499/0001562180-20-006499-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006500/0001562180-20-006500-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006501/0001562180-20-006501-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000009/0001624404-19-000009-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000010/0001624404-19-000010-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000011/0001624404-19-000011-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000012/0001624404-19-000012-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000013/0001624404-19-000013-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000014/0001624404-19-000014-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000015/0001624404-19-000015-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/842023/000162440419000016/0001624404-19-000016-index.htm

Bio-Techne Corporation (TECH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bio-Techne Corporation (TECH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 59%
Institutional Ownership: 9581%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-04Norman David EansorPresident-Protein SciencesSell1,387.00198.68275,569.160.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000109/0000914190-20-000109-index.htm
2020-05-21Norman David EansorPresident-Protein SciencesSell900.00268.89241,996.500.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2020-05-22Norman David EansorPresident-Protein SciencesSell4,924.00268.411,321,636.070.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2020-05-28Norman David EansorPresident-Protein SciencesSell3,448.00260.19897,134.090.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2020-05-29Norman David EansorPresident-Protein SciencesSell709.00264.01187,184.440.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2019-06-12Norman David EansorSVP - Novus BiologicalsSell3,117.00215.00670,155.000.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003526/0001562180-19-003526-index.htm
2019-09-09Charles R. KummethChief Executive OfficerBuy100.00185.0018,500.00100.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000370/0000914190-19-000370-index.htm
2019-07-10Charles R. KummethChief Executive OfficerSell6,566.00212.751,396,910.59102,579.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-12-12Brenda S. FurlowSVP - General CounselSell426.00214.3291,300.1510,285.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm
2020-05-28Brenda S. FurlowSVP - General CounselBuy1,600.0094.35150,960.0010,306.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm
2020-10-29RUPERT VESSEYDirectorBuy391.001,033.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006499/0001562180-20-006499-index.htm
2020-11-04James HippelChief Financial OfficerSell1,600.00274.53439,254.4010,337.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2020-11-05James HippelChief Financial OfficerSell3,249.00287.98935,648.3210,346.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-08-07Charles R. KummethChief Executive OfficerBuy11,291.00103,467.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000256/0000914190-19-000256-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell2,042.00273.33558,143.3310,403.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2020-07-06James HippelChief Financial OfficerSell1,934.00273.71529,358.0410,576.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2019-12-12Brenda S. FurlowSVP - General CounselBuy8,000.0094.35754,800.0010,711.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm
2019-07-09Charles R. KummethChief Executive OfficerBuy15,037.0067.461,014,396.02107,213.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-11-22James HippelChief Financial OfficerSell22,051.00215.554,753,051.1510,907.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-07-10Charles R. KummethChief Executive OfficerBuy16,969.0067.461,144,728.74109,145.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-07-08Charles R. KummethChief Executive OfficerBuy17,994.0067.461,213,875.24110,170.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2020-05-21Norman David EansorPresident-Protein SciencesBuy11,037.0094.351,041,340.9511,037.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2019-08-13Charles R. KummethChief Executive OfficerBuy7,410.0067.46499,878.60110,877.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000308/0000914190-19-000308-index.htm
2020-05-21ROBERT V BAUMGARTNERDirectorSell1,601.00266.07425,979.0311,320.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm
2020-08-09James HippelChief Financial OfficerBuy4,438.0011,321.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000290/0000914190-20-000290-index.htm
2020-07-07James HippelChief Financial OfficerSell414.00270.56112,010.4711,470.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-07-07James HippelChief Financial OfficerBuy2,577.00108.49279,578.7311,884.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-11-04James HippelChief Financial OfficerSell2,745.00273.65751,156.6211,937.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-11-25Roeland NusseDirectorSell8,347.00219.331,830,730.8212,374.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell505.00272.48137,601.2912,445.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2020-07-06James HippelChief Financial OfficerSell4,947.00272.341,347,256.0912,510.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2018-10-25Alpna SethDirectorBuy514.001,253.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004308/0001562180-18-004308-index.htm
2018-10-25JOSEPH D KEEGANDirectorBuy514.001,253.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004305/0001562180-18-004305-index.htm
2020-05-22Norman David EansorPresident-Protein SciencesBuy8,637.00108.49937,028.1312,600.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2018-08-24ROBERT V BAUMGARTNERDirectorBuy5,000.0061.46307,300.0012,712.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm
2020-10-29Roeland NusseDirectorBuy391.0012,765.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006492/0001562180-20-006492-index.htm
2020-05-21ROBERT V BAUMGARTNERDirectorSell1,300.00265.35344,959.8112,921.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell440.00270.97119,225.0012,950.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2019-12-20Charles R. KummethChief Executive OfficerSell5,767.00222.061,280,631.55129,989.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000520/0000914190-19-000520-index.htm
2019-12-23Charles R. KummethChief Executive OfficerSell659.00222.08146,350.85129,989.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm
2019-12-24Charles R. KummethChief Executive OfficerSell471.00222.18104,648.38129,989.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm
2020-01-02Charles R. KummethChief Executive OfficerSell92.00221.1320,343.50129,989.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-01-03Charles R. KummethChief Executive OfficerSell1,741.00218.23379,938.43129,989.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-01-06Charles R. KummethChief Executive OfficerSell10,276.00217.282,232,769.28129,989.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/0000914190-20-000018-index.htm
2020-01-02Charles R. KummethChief Executive OfficerSell775.00220.28170,717.00130,081.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2018-08-23JOHN L HIGGINSDirectorBuy10,000.0061.08610,800.0013,012.00https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm
2019-12-24Charles R. KummethChief Executive OfficerBuy471.0067.4631,773.66130,460.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm
2019-12-23Charles R. KummethChief Executive OfficerBuy659.0067.4644,456.14130,648.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm
2020-01-02Charles R. KummethChief Executive OfficerSell9,245.00219.322,027,613.40130,856.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-01-03Charles R. KummethChief Executive OfficerSell6,258.00217.371,360,301.46131,730.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2018-08-08Charles A DinarelloDirectorBuy5,000.0063.03315,150.0013,212.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselBuy9,079.00108.49984,980.7113,390.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2019-12-20Charles R. KummethChief Executive OfficerBuy5,767.0067.46389,041.82135,756.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000520/0000914190-19-000520-index.htm
2019-11-29Charles R. KummethChief Executive OfficerSell100.00222.6222,262.36135,756.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2019-12-10Charles R. KummethChief Executive OfficerSell703.00222.01156,073.03135,756.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000476/0000914190-19-000476-index.htm
2019-08-19Charles R. KummethChief Executive OfficerBuy24,979.00135,856.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000329/0000914190-19-000329-index.htm
2019-11-27Charles R. KummethChief Executive OfficerSell11,772.00222.122,614,814.30135,856.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2020-11-05James HippelChief Financial OfficerSell121.00287.1534,745.0713,595.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-12-10Charles R. KummethChief Executive OfficerBuy703.0067.4647,424.38136,459.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000476/0000914190-19-000476-index.htm
2020-11-05James HippelChief Financial OfficerSell1,630.00285.12464,739.9013,716.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2020-01-03Charles R. KummethChief Executive OfficerBuy7,999.0067.46539,612.54137,988.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-01-02Charles R. KummethChief Executive OfficerSell3,282.00218.42716,854.44140,101.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-01-06Charles R. KummethChief Executive OfficerBuy10,276.0067.46693,218.96140,265.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/0000914190-20-000018-index.htm
2020-05-21ROBERT V BAUMGARTNERDirectorBuy5,000.0070.35351,750.0014,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm
2020-01-02Charles R. KummethChief Executive OfficerSell6,449.00217.401,402,012.60143,383.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-11-04James HippelChief Financial OfficerSell1,555.00272.71424,063.8914,682.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-07-01RUPERT VESSEYDirectorBuy147.00147.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003807/0001562180-19-003807-index.htm
2019-11-27Charles R. KummethChief Executive OfficerBuy11,772.0067.46794,139.12147,628.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm
2020-01-02Charles R. KummethChief Executive OfficerBuy19,843.0067.461,338,608.78149,832.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm
2020-05-26Charles R. KummethChief Executive OfficerBuy21,159.0086.251,824,963.75151,148.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000186/0000914190-20-000186-index.htm
2020-08-05Charles R. KummethChief Executive OfficerBuy8,586.00152,483.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/0000914190-20-000253-index.htm
2020-11-05James HippelChief Financial OfficerSell325.00283.6492,183.0015,346.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2020-11-05James HippelChief Financial OfficerSell1,674.00282.52472,938.9815,671.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-11-25Roeland NusseDirectorBuy10,000.0060.46604,600.0015,721.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2020-11-04James HippelChief Financial OfficerBuy7,100.00108.49770,279.0016,237.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-05-01Kim KeldermanPresident, Diagnostics & GenomBuy1,667.00202.13336,950.711,667.00https://www.sec.gov/Archives/edgar/data/842023/000156218019002478/0001562180-19-002478-index.htm
2020-11-05James HippelChief Financial OfficerSell203.00281.2757,098.6417,345.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2020-08-09Charles R. KummethChief Executive OfficerBuy21,291.00173,774.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000289/0000914190-20-000289-index.htm
2020-07-06James HippelChief Financial OfficerSell3,781.00271.531,026,667.4117,457.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2019-10-24Alpna SethDirectorBuy495.001,748.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000011/0001624404-19-000011-index.htm
2019-10-24JOSEPH D KEEGANDirectorBuy495.001,748.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000016/0001624404-19-000016-index.htm
2020-11-05James HippelChief Financial OfficerSell398.00280.28111,550.2517,548.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2020-11-05James HippelChief Financial OfficerBuy8,809.00108.49955,688.4117,946.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-11-21James HippelChief Financial OfficerBuy11,349.0094.351,070,778.1520,656.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-11-25Roeland NusseDirectorBuy5,000.0061.46307,300.0020,721.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm
2020-07-06James HippelChief Financial OfficerSell9,571.00270.452,588,507.5821,238.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-10-29Alpna SethDirectorBuy391.002,139.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006487/0001562180-20-006487-index.htm
2020-10-29JOSEPH D KEEGANDirectorBuy391.002,139.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006491/0001562180-20-006491-index.htm
2020-08-09Norman David EansorPresident-Protein SciencesBuy2,174.002,174.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000291/0000914190-20-000291-index.htm
2019-05-24Brenda S. FurlowSVP - General CounselSell5,400.00200.001,080,000.002,189.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm
2018-05-04Norman David EansorSVP - Novus BiologicalsSell1,136.00145.19164,931.752,266.00https://www.sec.gov/Archives/edgar/data/842023/000156218018002455/0001562180-18-002455-index.htm
2019-08-19Norman David EansorSVP - Novus BiologicalsBuy2,287.002,287.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000331/0000914190-19-000331-index.htm
2020-05-01Kim KeldermanPres. Diagnostics & GenomBuy1,666.002,489.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000167/0000914190-20-000167-index.htm
2018-08-07Brenda S. FurlowSVP - General CounselBuy959.002,627.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/0001562180-18-003543-index.htm
2019-12-12Brenda S. FurlowSVP - General CounselSell200.00216.7543,350.002,711.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm
2020-05-29Norman David EansorPresident-Protein SciencesSell3,400.00261.74889,926.542,809.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2019-12-12Brenda S. FurlowSVP - General CounselSell4,147.00216.01895,783.932,911.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm
2018-08-23JOHN L HIGGINSDirectorSell10,000.00187.921,879,173.003,012.00https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm
2020-07-06James HippelChief Financial OfficerBuy21,502.00108.492,332,751.9830,809.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2019-11-22James HippelChief Financial OfficerBuy23,651.0094.352,231,471.8532,958.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2020-05-28Norman David EansorPresident-Protein SciencesBuy3,448.00108.49374,073.523,448.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2018-08-07Norman David EansorSVP - Novus BiologicalsBuy1,199.003,465.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003544/0001562180-18-003544-index.htm
2018-10-25JOHN L HIGGINSDirectorBuy514.003,526.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004304/0001562180-18-004304-index.htm
2019-06-04JOHN L HIGGINSDirectorSell5,000.00203.671,018,345.503,526.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm
2019-05-01James HippelChief Financial OfficerBuy35,000.0086.253,018,750.0039,382.00https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm
2019-08-19Brenda S. FurlowSVP - General CounselBuy1,759.003,948.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/0000914190-19-000328-index.htm
2020-05-22Norman David EansorPresident-Protein SciencesBuy3,963.0094.35373,909.053,963.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2019-10-24JOHN L HIGGINSDirectorBuy495.004,021.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000010/0001624404-19-000010-index.htm
2020-02-12JOHN L HIGGINSDirectorSell5,000.00205.231,026,132.504,021.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000070/0000914190-20-000070-index.htm
2018-10-25RANDOLPH C STEERDirectorBuy514.004,226.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004309/0001562180-18-004309-index.htm
2020-05-28Brenda S. FurlowSVP - General CounselSell3,800.00260.38989,453.504,311.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell74.00278.8420,634.164,311.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2019-05-01James HippelChief Financial OfficerSell35,000.00203.087,107,681.004,382.00https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell2,746.00278.06763,555.514,385.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2020-10-29JOHN L HIGGINSDirectorBuy391.004,412.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006489/0001562180-20-006489-index.htm
2019-10-24RANDOLPH C STEERDirectorBuy495.004,721.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000013/0001624404-19-000013-index.htm
2018-10-25HAROLD J WIENSDirectorBuy514.004,726.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004307/0001562180-18-004307-index.htm
2020-10-29Julie L BushmanDirectorBuy391.00480.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006488/0001562180-20-006488-index.htm
2020-05-29HAROLD J WIENSDirectorSell3,985.00260.001,036,100.004,843.00https://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm
2020-05-22Norman David EansorPresident-Protein SciencesSell7,676.00267.632,054,289.504,924.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2020-10-29RANDOLPH C STEERDirectorBuy391.005,112.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006500/0001562180-20-006500-index.htm
2019-10-24HAROLD J WIENSDirectorBuy495.005,221.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000015/0001624404-19-000015-index.htm
2019-12-04HAROLD J WIENSDirectorSell80.00219.3117,545.115,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2020-04-30HAROLD J WIENSDirectorSell4,000.00225.00900,000.005,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000160/0000914190-20-000160-index.htm
2020-05-06HAROLD J WIENSDirectorSell4,260.00250.001,065,000.005,221.00https://www.sec.gov/Archives/edgar/data/842023/000156218020003482/0001562180-20-003482-index.htm
2018-10-25Roeland NusseDirectorBuy514.005,226.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004306/0001562180-18-004306-index.htm
2019-12-04HAROLD J WIENSDirectorSell921.00218.75201,472.895,301.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2018-08-07James HippelChief Financial OfficerBuy2,398.005,477.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003542/0001562180-18-003542-index.htm
2019-10-24Roeland NusseDirectorBuy495.005,721.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000012/0001624404-19-000012-index.htm
2020-08-09Brenda S. FurlowSVP - General CounselBuy1,724.006,035.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000292/0000914190-20-000292-index.htm
2020-05-29Norman David EansorPresident-Protein SciencesSell1,700.00260.83443,409.646,209.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2019-12-04HAROLD J WIENSDirectorSell514.00217.29111,684.596,222.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-10-24RUPERT VESSEYDirectorBuy495.00642.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000014/0001624404-19-000014-index.htm
2019-12-04HAROLD J WIENSDirectorSell485.00216.47104,990.236,736.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-12-12Brenda S. FurlowSVP - General CounselSell3,227.00215.17694,337.787,058.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm
2020-05-29Norman David EansorPresident-Protein SciencesSell2,100.00262.68551,619.39709.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell1,954.00277.28541,812.157,131.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2019-12-04HAROLD J WIENSDirectorBuy2,000.0087.83175,660.007,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm
2019-05-24Brenda S. FurlowSVP - General CounselBuy5,400.007,589.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm
2018-06-07Charles R. KummethChief Executive OfficerSell8,000.00160.001,280,000.0076,472.00https://www.sec.gov/Archives/edgar/data/842023/000156218018002938/0001562180-18-002938-index.htm
2018-08-24ROBERT V BAUMGARTNERDirectorSell5,000.00188.47942,333.507,712.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm
2020-05-29Norman David EansorPresident-Protein SciencesBuy7,909.00108.49858,047.417,909.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm
2020-05-28Brenda S. FurlowSVP - General CounselSell2,195.00259.72570,079.258,111.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm
2018-08-08Charles A DinarelloDirectorSell5,000.00176.94884,675.008,212.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm
2018-10-25ROBERT V BAUMGARTNERDirectorBuy514.008,226.00https://www.sec.gov/Archives/edgar/data/842023/000156218018004303/0001562180-18-004303-index.htm
2019-06-04JOHN L HIGGINSDirectorBuy5,000.0063.03315,150.008,526.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm
2020-05-28Brenda S. FurlowSVP - General CounselBuy5,995.00108.49650,397.558,706.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm
2019-08-07ROBERT V BAUMGARTNERDirectorBuy500.00191.0695,530.008,726.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000261/0000914190-19-000261-index.htm
2020-05-29HAROLD J WIENSDirectorBuy3,985.00101.19403,242.158,828.00https://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm
2020-08-03Julie L BushmanDirectorBuy89.0089.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005331/0001562180-20-005331-index.htm
2020-05-21Norman David EansorPresident-Protein SciencesSell10,137.00267.372,710,319.55900.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm
2020-02-12JOHN L HIGGINSDirectorBuy5,000.0061.46307,300.009,021.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000070/0000914190-20-000070-index.htm
2018-08-07Charles R. KummethChief Executive OfficerBuy13,816.0090,288.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell400.00276.03110,410.009,085.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2020-11-04James HippelChief Financial OfficerSell1,200.00275.79330,951.729,137.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2020-11-05James HippelChief Financial OfficerSell100.00293.6629,366.009,137.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-07-08Charles R. KummethChief Executive OfficerSell17,994.00212.753,828,183.9192,176.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-07-09Charles R. KummethChief Executive OfficerSell15,037.00212.433,194,339.9892,176.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm
2019-07-10Charles R. KummethChief Executive OfficerSell494.00214.07105,749.6992,176.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2020-04-30HAROLD J WIENSDirectorBuy4,000.0091.78367,120.009,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000160/0000914190-20-000160-index.htm
2019-10-24ROBERT V BAUMGARTNERDirectorBuy495.009,221.00https://www.sec.gov/Archives/edgar/data/842023/000162440419000009/0001624404-19-000009-index.htm
2020-05-21ROBERT V BAUMGARTNERDirectorSell125.00267.9433,492.589,221.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm
2020-11-05James HippelChief Financial OfficerSell750.00291.06218,297.039,237.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm
2019-07-10Charles R. KummethChief Executive OfficerSell9,909.00213.322,113,768.0692,670.00https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm
2019-08-19James HippelChief Financial OfficerBuy4,925.009,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000330/0000914190-19-000330-index.htm
2019-11-21James HippelChief Financial OfficerSell11,349.00215.362,444,131.999,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2019-11-22James HippelChief Financial OfficerSell1,600.00216.16345,850.249,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm
2020-07-06James HippelChief Financial OfficerSell1,269.00274.52348,362.969,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-07-07James HippelChief Financial OfficerSell500.00272.26136,130.009,307.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-05-21ROBERT V BAUMGARTNERDirectorSell1,974.00267.32527,685.349,346.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm
2018-08-08Charles R. KummethChief Executive OfficerBuy11,279.0093,514.00https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm
2020-05-06HAROLD J WIENSDirectorBuy4,260.0087.34372,068.409,481.00https://www.sec.gov/Archives/edgar/data/842023/000156218020003482/0001562180-20-003482-index.htm
2020-07-09Brenda S. FurlowSVP - General CounselSell918.00274.80252,270.819,485.00https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm
2020-10-29ROBERT V BAUMGARTNERDirectorBuy391.009,612.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006501/0001562180-20-006501-index.htm
2020-07-07James HippelChief Financial OfficerSell1,663.00271.40451,341.369,807.00https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm
2020-11-05James HippelChief Financial OfficerSell359.00289.39103,889.509,987.00https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm